Latam BioHoldings Co.
A U.S.-based translational platform bridging the gap between world-class Latin American biomedical research and international clinical development.
The region hosts leading research institutions producing significant scientific output that remains largely under-accessed by global capital and clinical infrastructure. We are here to change that. We approach this with rigor, respect for academic mission, and a clear path to international validation.
Significant scientific output
Latin America's leading research universities produce a substantial and growing volume of biomedical discoveries. Much of this work remains unknown to global clinical and investment communities.
A structural gap, not a temporary one
The path from regional academic discovery to international clinical validation is long and poorly served. LBH exists to bridge that gap with discipline and long-term commitment to the region.
Whether you represent a scientific discovery, an operational capability, or an investment mandate, we want to hear from you.
Scientific Assets
We seek validated biological or chemical discoveries from academic and institutional research groups across Latin America. Early-stage discoveries are welcome. We evaluate scientific merit, not just development stage.
Operational Partners
We collaborate with CROs, specialized labs, and regulatory specialists who share our commitment to rigorous, reproducible science aligned with international clinical standards.
Strategic Partners
We engage with investors, family offices, and institutional partners who understand the LATAM biomedical opportunity and are looking for a disciplined, US-led translational engine.
We maintain active relationships with research institutions across the region, with a focus on markets that combine scientific output, regulatory alignment, and clinical infrastructure.
If you are a researcher, TTO, or academic institution in Latin America with a promising biological or chemical discovery, we would like to hear about your science.
All disclosures handled under standard confidentiality agreements.
If you represent an investment mandate, operational capability, or institutional interest aligned with LATAM biomedical translation, we welcome a conversation.
We respond within a few business days.